Particulars (Rupees in Crores.) | Dec-2024 | Sept-2024 | Jun-2024 | Mar-2024 | Dec-2023 |
---|---|---|---|---|---|
Gross Sales | 704.45 | 733.76 | 741.81 | 659.99 | 677.5 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 704.45 | 733.76 | 741.81 | 659.99 | 677.5 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 13.85 | 12.53 | 13.72 | 12.97 | 10.59 |
Total Income | 718.3 | 746.29 | 755.53 | 672.96 | 688.09 |
Total Expenditure | 588.7 | 595.31 | 608.36 | 551.61 | 558.87 |
PBIDT | 129.6 | 150.98 | 147.17 | 121.35 | 129.22 |
Interest | 1.48 | 1.4 | 1.39 | 1.26 | 1.19 |
PBDT | 128.12 | 149.58 | 145.78 | 120.09 | 128.03 |
Depreciation | 14.28 | 13.89 | 13.41 | 12.86 | 12.83 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 19.98 | 24.08 | 22.94 | 18.53 | 20.09 |
Deferred Tax | 6.46 | 6.59 | 7.74 | 10.55 | 4.19 |
Reported Profit After Tax | 87.4 | 105.02 | 101.69 | 78.15 | 90.92 |
Minority Interest After NP | -0.01 | 0.03 | -0.04 | -0.01 | 0.03 |
Net Profit after Minority Interest | 87.41 | 104.99 | 101.73 | 78.16 | 90.89 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 87.41 | 104.99 | 101.73 | 78.16 | 90.89 |
EPS (Unit Curr.) | 2.38 | 2.86 | 2.77 | 2.13 | 2.48 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 18.39 | 20.57 | 19.83 | 18.38 | 19.07 |
PBDTM(%) | 18.18 | 20.38 | 19.65 | 18.19 | 18.89 |
PATM(%) | 12.4 | 14.31 | 13.7 | 11.84 | 13.41 |
The sale was approved by the Board of Directors at a meeting held on March 25, 2025. Post sale, JKBL ceases to be a subsidiary of Jyothy Labs.
Operating EBITDA grew by 2.3% YoY, reaching ₹138.5 Crore, up from ₹135.4 Crore in the previous year’s Q2.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.